Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin. [electronic resource]
Producer: 20180214Description: 422-431 p. digitalISSN:- 1549-490X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anthracyclines -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cardiotoxicity -- drug therapy
- Doxorubicin -- administration & dosage
- Drug Delivery Systems
- Female
- Heart -- drug effects
- Heart Diseases -- chemically induced
- Hodgkin Disease -- complications
- Humans
- Liposomes -- chemistry
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.